EPA faces suit over plan to release genetically engineered mosquitoes
By Rachel Franzin,
The Hill
| 06. 15. 2020
The Center for Food Safety, the International Center for Technology Assessment and Friends of the Earth allege that the EPA violated the law.
The Environmental Protection Agency (EPA) is facing a lawsuit over its approval of a plan to release genetically modified mosquitoes in Florida and Texas.
Several groups, including the Center for Food Safety, the International Center for Technology Assessment and Friends of the Earth filed a notice of intent to sue on Friday. They alleged that the EPA violated the law by failing to consult with wildlife agencies before determining that the mosquitoes will not pose risks to threatened species.
“EPA’s ‘no effect’ findings and failure to consult are arbitrary and capricious and violate the ESA [Endangered Species Act] because they fail to follow the ESA’s mandated procedures, fail to use the best scientific and commercial data available, fail to consider significant aspects of the issue, and offer an explanation that runs counter to the evidence before the agency,” the groups claimed in their notice.
The EPA last month approved an experimental use permit for a company that wants to test the use of genetically engineered mosquitoes as a way to try to reduce mosquito populations and protect people from mosquito-borne illnesses.
According...
Related Articles
By Erik Adams, Sundance | 09.08.2026
The scariest movie playing at the 2026 Sundance Film Festival isn’t about cursed audio recordings or a killer demon disguised as your true love; rather it’s a 110-minute essay film about how a handful of guys obsessed with numbers and...
By Katie Bo Lillis and Zachary Cohen, CNN | 09.18.2026
The intelligence report, circulated across the US military this spring in the midst of the war with Iran, immediately set off alarm bells: A Chinese ship in the Middle East was transporting components of a nuclear weapons program.
The US...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
By Karen Weintraub, Endpoints News | 09.16.2026
To better understand certain neuropsychiatric disorders, researchers at Stanford University have bred rodents that lack a cortex and hippocampus and then replaced those missing brain cells with human ones.
The altered mice, a scientific first, provided insights that would not...